CYP26C1: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 27: Line 27:
{{gene-stub}}
{{gene-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 05:57, 17 March 2025

CYP26C1 is a member of the cytochrome P450 superfamily of enzymes. These enzymes are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. The CYP26C1 gene is located on chromosome 10 in humans.

Function[edit]

CYP26C1 is primarily involved in the metabolism of retinoic acid, a derivative of vitamin A that plays a crucial role in cell growth, differentiation, and embryonic development. The enzyme helps to regulate the levels of retinoic acid by converting it into hydroxylated forms, which are then further metabolized and excreted from the body. This regulation is essential for maintaining proper cellular function and preventing the toxic effects of excess retinoic acid.

Gene Structure[edit]

The CYP26C1 gene consists of several exons and introns, which are transcribed and spliced to produce the mature mRNA. The gene is expressed in various tissues, including the liver, kidney, and brain, indicating its widespread role in retinoic acid metabolism.

Clinical Significance[edit]

Mutations or alterations in the CYP26C1 gene can lead to abnormal retinoic acid levels, which may result in developmental disorders and diseases. For example, improper regulation of retinoic acid has been linked to conditions such as congenital diaphragmatic hernia and caudal regression syndrome. Research is ongoing to better understand the role of CYP26C1 in these and other conditions.

Related Enzymes[edit]

CYP26C1 is part of a subfamily of enzymes that includes CYP26A1 and CYP26B1. These enzymes share similar functions in retinoic acid metabolism but may have different tissue distributions and substrate specificities.

Research and Future Directions[edit]

Ongoing research aims to elucidate the detailed mechanisms by which CYP26C1 regulates retinoic acid levels and to explore its potential as a therapeutic target. Understanding the enzyme's structure and function could lead to the development of drugs that modulate its activity, offering new treatments for diseases related to retinoic acid imbalance.

See Also[edit]

References[edit]

<references group="" responsive="1"></references>


External Links[edit]

Stub icon
   This article is a gene stub. You can help WikiMD by expanding it!